Creatine analogs having antiviral activity
CA 2125563 A1 · Owner: Lillie, James W. · Inventors: Kaddurah-Daouk, Rima; Lillie, James W.; Burbaum, Jonathan J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of creatine and suitable creatine analogs, such as cyclocreatine as antiviral agents. These compounds can be used as antiviral agents against a variety of viruses, particularly DNA viruses, such as Herpes viruses (e.g. HSV-1, HSV-2, cytomegaloviruses, Varicella-Zoster virus) and adenovirus. The invention further relates to suitable creatine analogs having antiviral activity, including creatine analogs that can be phosphorylated by creatine kinase and the phosphorylated forms of the creatine analogs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 21, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 21, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 21, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.